A USFDA Warning Letter and a 15 Working Day Clock: What Recall and BI Cover Do Next

On 5 August 2026, Moneycontrol reported that the USFDA issued a warning letter to Dabur India over current good manufacturing practice violations at its Silvassa plant. Sahi reported the same action that day, framing the finding as inadequate quality systems and noting that the company must respond within 15 working days.

That 15 working day window is the part a risk manager should read twice. A warning letter is not a penalty or a ban. It is a written statement that the agency considers the violations significant enough to warrant a documented corrective response, on a short deadline. What happens after the response is where the commercial exposure sits. A response the agency finds adequate closes the matter. One it finds inadequate, or a repeat finding at the same site, moves the firm toward detention without physical examination of its shipments, the mechanism an import alert operates through.

The domestic regulator moves the same way on a shorter runway. The Economic Times reported on 24 July 2026 that FSSAI suspended the licence of Punjab-based Rehaan Healthcare for breach of norms at its manufacturing unit. A suspension does not require a consumer to fall ill or a batch to fail. It requires an inspector to find non-conformity and an authority to act on it. The output is the same in both cases: production or distribution stops, revenue stops, and nothing has physically happened to the insured's property.

Most Indian recall and contamination programmes are not built for that sequence. They are built for a defective batch that reaches the market and hurts someone.

Indian first-party property and business interruption cover is built on physical damage. A standard fire and special perils policy indemnifies material damage to insured property from a named peril, and the business interruption section attaches to that material damage: the loss of gross profit must arise from an interruption caused by damage that the material damage section would itself have paid. No damage, no interruption claim.

A warning letter destroys none of it. The plant is intact, the utilities run, the stock is saleable in every physical sense. What has changed is the legal permission to ship it into a particular market. The economic loss can be larger than a fire at the same site, because an import alert closes an entire export channel rather than one production line, and because it persists until the firm has satisfied the agency rather than until a contractor has rebuilt a shed.

The three covers a manufacturer typically holds each miss this differently:

• Fire and business interruption misses it because there is no material damage to attach to, so the business interruption section never triggers.
• Product liability misses it because there is no third-party bodily injury or property damage to indemnify.
• Product recall or contamination often misses it because the trigger is drafted around accidental contamination, a safety hazard or malicious tampering, and a quality systems finding is none of those.

A first-party product recall expense policy pays the insured's own cost of getting product back. The heads of cover are narrow and specific:

1. Recall expenses: notifying distributors and customers, the logistics of recovering stock from the trade, transport, temporary storage, additional staff and overtime, and destruction or disposal.
2. Replacement or rectification cost: replacing recalled units or reworking them into conforming product, usually at cost of manufacture rather than sale price.
3. Lost gross profit on the recalled product, where a recall business interruption extension exists, usually sub-limited well below the main recall limit.
4. Consultant and crisis management fees: recall consultants, regulatory advisers and public relations support, often on a panel basis where the insurer names the firms.
5. Rehabilitation expense: the advertising and trade support spend to restore the product's sales after the recall, again heavily sub-limited and often time barred.

What the section does not pay for, unless specifically extended, is the cost of not being allowed to sell. If the plant is barred from shipping to a market, no product has been recalled. There is nothing to recover, nothing to destroy, nothing to replace, and every head of cover above is written around the movement of goods back up the chain.

The same logic applies to the deductible. Recall wordings commonly carry a time deductible measured from the decision to recall. A regulatory stop-ship has no recall decision date, so even where an insurer is sympathetic, the mechanics of the wording do not produce a claim.

A product liability policy indemnifies the insured against legal liability to third parties for accidental bodily injury or property damage caused by a product after it has left the insured's premises. The trigger is harm to someone else, which makes its role in a regulatory event secondary.

A quality systems finding raises the probability that some product made under those systems was out of specification. If that product reached patients or consumers and caused harm, a liability claim follows, and the regulator's own findings become the claimant's best evidence of defect. The regulatory record is what makes such a claim expensive to defend.

The liability policy does not pay:

• The cost of the recall itself, which the standard recall and withdrawal exclusion carves out of the liability section.
• Regulatory fines, penalties and the cost of remediating a plant to the agency's satisfaction, which sit under the fines and penalties exclusion.
• Pure financial loss to customers who received goods late or not at all, unaccompanied by injury or property damage.
• The insured's own lost margin on shipments it cannot make.

For an exporter there is a further dimension. Product sold into the United States creates liability exposure under United States law, so the placement has to address whether the Indian policy is admitted or non-admitted for that territory, whether defence costs sit inside or outside the limit, and whether the jurisdiction clause reaches United States judgments. A warning letter is a signal to test all three.

A regulatory shutdown or import alert needs its own named trigger. It should never be assumed into the recall section, which is drafted around the physical movement of product. The extensions worth naming at placement are:

Government-mandated and regulatory recall. The narrowest of the useful extensions and the one most often already present. It converts the trigger from the insured's own decision to recall into a recall ordered by a competent authority. It helps where the regulator orders product back and does nothing where the regulator refuses future entry.

Regulatory shutdown or denial of access business interruption. The extension that responds to the Silvassa or Rehaan Healthcare shape of event. It pays loss of gross profit arising from the closure, suspension or restriction of the insured's premises or operations by order of a public authority, without requiring physical damage. It is usually written with a short indemnity period, a hard sub-limit, a waiting period of several days, and an exclusion for closure arising from the insured's own wilful non-compliance. All four are negotiable at placement and none of them after the letter arrives.

Import alert and export licence extension. A rarer wording responding specifically to the loss of the right to ship into a named territory. Where export revenue is concentrated in one regulated market it matches the actual exposure, and it should be sized against export gross profit from that market rather than total turnover.

The day the warning letter is received, the firm's insurance position changes for every renewal and every new placement that follows, whether or not a claim is ever made.

Recall, liability and management liability wordings carry three provisions that key off knowledge:

1. The prior knowledge or known circumstances exclusion, excluding loss arising from any circumstance the insured knew, or ought reasonably to have known, was likely to give rise to a claim at or before inception.
2. The claims-made and notified trigger on liability and management liability covers, under which a circumstance notified during the current period is deemed to attach to that period and not to a later one.
3. The duty of disclosure, resting on the general law of utmost good faith for commercial lines, which makes a material non-disclosure at renewal a defence to a later claim.

A firm that receives a warning letter in August and renews its recall and liability programme in October has a hard choice. Disclose, and the incoming insurer will exclude the site, exclude the regulatory matter, load the rate, or all three. Fail to disclose, and it has paid a premium for a policy the insurer can decline on when the matter matures into a claim.

The better move is to notify the existing insurer as a circumstance before the renewal, in writing, with the letter attached, and then disclose fully at renewal. A notified circumstance attaches to the policy period in which it was notified, so the cover in force when the letter arrived is the cover that responds, at that period's limit and terms.

The window between the letter and the response

The 15 working day response window is also an insurance window. Whatever the firm writes to the regulator is a document the insurer will read later. A response conceding that the systems were known to be deficient for a long period hands the prior knowledge exclusion its factual basis. A response that dates each deficiency and the action taken against it does the opposite. The regulatory reply and the insurance position are the same facts, drafted once.

From the day the letter arrives, the firm should build a record a loss adjuster can follow eighteen months later. Every disputed regulatory claim turns on two questions, both answered by contemporaneous documents or not at all: when did you first know, and what did you do about it. The file should contain, in dated form:

• The inspection observations, the warning letter and every subsequent agency communication, filed by date received rather than by date actioned.
• The internal escalation record showing when each finding reached quality leadership and the board or audit committee.
• The corrective and preventive action plan with owners and target dates, and evidence of completion against each item.
• Batch records, deviation logs and out-of-specification investigations for the periods the agency identified, preserved rather than allowed to age out of retention.
• Every commercial consequence, dated: cancelled purchase orders, held shipments, customer notifications, distributor claims, and the margin attributable to each.
• The circumstance notification to insurers and the insurer's acknowledgement.

That last line is the one firms most often fail to keep. A regulatory business interruption claim is quantified from lost gross profit on shipments that did not happen, and those leave no invoice. The only proof is the order book, the historical shipping pattern to the affected market, and the correspondence in which customers withdrew or resourced. A surveyor appointed a year later cannot reconstruct that from accounting records alone.

The practical test is a narrow one. Could the firm prove, from documents alone, that it did not know its quality systems were deficient before the inception date of the policy it is claiming under? If it cannot, the prior knowledge exclusion is live regardless of what actually happened.

The response window is short, and the insurance work fits inside it if it is sequenced.

1. Notify as a circumstance, in writing, immediately. Attach the letter. Do not wait for the response to be finalised or for the matter to escalate. Notification costs nothing and preserves the attachment of the current policy period.
2. Pull the wordings and read three things: the recall trigger, whether the business interruption trigger requires material damage, and the prior knowledge provisions in every policy in the programme, including directors and officers liability where the matter could produce a shareholder action.
3. Quantify the exposed revenue by market. Export gross profit into the regulated territory, split by plant, sizes any extension worth buying. Total turnover does not.
4. Ask the insurer the shutdown question in writing and keep the answer. If the recall section does not reach a public authority restriction without physical damage, that is a gap to price and close at renewal, not argue about at claim stage.
5. Start the dated file on day one, owned by someone other than the person drafting the regulatory response.

Regulatory action is a distinct trigger with a distinct evidence requirement, sitting in the space between three policies that were each designed for something else. Firms with concentrated export exposure to a single regulated market should treat the regulatory extension as a core line item and size it against the revenue that one agency decision can switch off.

For brokers testing whether a client's recall, liability and business interruption wordings actually reach a regulatory shutdown, the work is in the comparison: which insurers write a denial of access or public authority extension without a material damage precondition, what indemnity periods and sub-limits they attach, and how each drafts the prior knowledge exclusion. Sarvada gives commercial insurance brokers structured, searchable access to insurer policy wordings so those triggers, extensions and exclusions can be compared side by side against a client's actual regulatory exposure. Request Access to evaluate the platform for product recall and regulatory business interruption placements.